Ambient Biosciences, Inc.
Room-temperature biological sample stabilization technology that eliminates cold chain and lyophilization requirements
- Sector
- Biotech
- Headquarters
- ANN ARBOR, MI
- Founded
- 2014
- Latest Form D
- $4.2M, Dec 2024
- Total capital
- $24.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $24.3M
- 4 Form D · last Dec 2024
- 23 months since last filing
- Federal contracts
- $180K
- 3 awards · Defense
- Rank in Biotech#301 of 4373
- Granted patents
- 3
- 11 pending · first 2025
- Rank in peer group#13 of 54
Capital timeline
Latest events
- Federal contractDefense · Ambient Biosciences 8400 Research Plazafort Detrick, Md 21702$59K
- Federal contractDefense · Ambient Bioscience Reagent Stabilizer With Installation And Training$70K
- Federal contractDefense · Ambient Stabilizer To Include Ambiset 15; Kit Biofix 35; Kit And Biofix 175 Kit At No Charge To The Government Per Quote Dated On 11/26/2024.$50K
- Private capital raisedForm D · SEC · 4th filing$4.2M
- Private capital raisedForm D · SEC · 3rd filing$9.2M
- Private capital raisedForm D · SEC · 2nd filing$4M
- Private capital raisedForm D · SEC · 1st filing$7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 54 peers
Line = medianBiotech · Material
- Granted patents#13 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Pravansu S. MohantyResearcherExecutive Officer, DirectorLinked by 2 patents
- Craig U. MansonExecutive OfficerNamed in SEC Form D filings
- Jack U. HoppinDirectorNamed in SEC Form D filings
- Matthew U. CobbettExecutive OfficerNamed in SEC Form D filings
- Paul U. MeisterDirectorNamed in SEC Form D filings
- Richard U. TroyerExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- William U. ParfetDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 14- New patentAmbient Temperature Lipid Particle Storage Systems And MethodsUSPTOUS 12,746,281
- GrantedDevice And Methods For Rapid Detection Of Target Analytes In A Biological SampleUSPTOUS 12,631,629
- PendingFunctional Wound Healing DressingsUSPTOApplication 19350571
Show all 14 patent records
- Ambient Temperature Lipid Particle Storage Systems And MethodsSep 29, 2026 · US 12,746,281Granted
- Device And Methods For Rapid Detection Of Target Analytes In A Biological SampleMay 19, 2026 · US 12,631,629Granted
- Functional Wound Healing DressingsJan 29, 2026 · Application 19350571Pending
- Functional Wound Healing DressingsNov 4, 2025 · US 12,458,538Granted
- Superconcentrated Formulations Of Bioactive AgentsAug 22, 2024 · Application 18571569Pending
- Ambient Temperature Lipid Particle Storage Systems And MethodsJan 11, 2024 · Application 18253077Pending
- Capillary Assisted Vitrification Processes And Materials For Preservation Of Biological SamplesMar 16, 2023 · Application 17904534Pending
- Device And Methods For Sensitive Biological Sample StorageApplication 19518421Pending
- Device And Methods For Detection Of An OrganismApplication PCTUS2024046881Pending
- Vitrified Reagents For Enhanced Transfection And Processes ThereofApplication PCTUS2025011791Pending
- Device And Methods For Sensitive Biological Sample StorageApplication PCTUS2024046878Pending
- Vitrified Reagents For Enhanced Transfection And Processes ThereofApplication 63621297Pending
- Device And Methods For Detection Of An OrganismApplication 19518429Pending
- Vitrified Reagents For Enhanced Transfection And Processes ThereofApplication 19605944Pending
Related companies, and why
- Angiocrine BioscienceSimilar federal contract value in Biotech · $189K in contracts
- Tenax TherapeuticsSimilar federal contract value in Biotech · $185K in contracts
- CANTATA BIO LLCSimilar federal contract value in Biotech · $182K in contracts
- INTACT GENOMICS INCSimilar federal contract value in Biotech · $168K in contracts
- REGIS TECHNOLOGIES INCSimilar federal contract value in Biotech · $160K in contracts
- Scale BiosciencesSimilar federal contract value in Biotech · $151K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .